Navigation Links
London Genetics and Astrimmune to Collaborate on Cancer Vaccine
Date:11/12/2010

mune's early-stage pancreatic cancer vaccine candidate, will be used in applications for further funding of its development. Financial terms were not disclosed.

Astrimmune's vaccine candidate induces the production of antibodies against gastrin, a hormone which is known to stimulate the growth of many types of gastrointestinal cancer. Since differential response rates have been observed in clinical trials of other gastrin-blocking products, with some patients responding very well and others hardly at all, there is a clear need for biomarkers to help identify those patients most likely to benefit from Astrimmune's product. For example, there is a possibility that the variable response rates may have been due in part to the inclusion of some patients with gastrin-insensitive tumours, or those not able to respond immunologically.

Under the terms of the collaboration, which is supported by a grant from the UK East Midlands Development Agency, London Genetics and Astrimmune will put together a proposal for identification of biomarkers predictive of clinical response. London Genetics' seven academic partners, which have an annual research budget of over GBP650m, are able to provide expertise in areas such as tumour biopsy samples and animal models, as well as expertise in the genetics of immune responses to cancer vaccines.

Dominique Kleyn, CEO of London Genetics, said, 'This collaboration is a significant pharmacogenetics development opportunity, and we are pleased to be working with Astrimmune on this important project. As exemplified by our recent collaboration with Diaceutics and increasingly recognised by the biopharmaceutical industry, pharmacogenetics, biomarkers and patient stratification are becoming an important part of the drug discovery and development process. London Genetics' network of over 3,000 academic groups makes it an ideal partner for pharma and biotech companies in this work.'

Fred Jacobs, Managing Director of Astrimm
'/>"/>

SOURCE London Genetics Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Diaceutics and London Genetics Partner to Accelerate Biomarker Development in the Global Biopharmaceutical Industry
2. OXIS International, Inc. Announces Its Attendance at the Rodman & Renshaw Annual Global Investment Conference in London, May 16-18, 2010
3. London Genetics Conference Proceedings Published in Drug Discovery Today
4. First Awards Made by London Genetics Proof-of-Concept Fund
5. Expanded London Genetics Web Site Emphasises Importance of Pharmacogenetics in Drug Development
6. Hologic to Present at NASDAQ OMX 23rd Investor Program in London
7. London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference
8. PRA International: Participating Sponsor for Exploratory Clinical Development World in London
9. Interleukin Genetics Reports Third Quarter 2010 Financial Results
10. Shire Presents Positive New Data at the 60th Annual American Society of Human Genetics (ASHG) for Patients with Type 1 Gaucher Disease
11. New England Biolabs Launches a Suite of Innovative Tools to Advance Epigenetics Research, Including PCR-Based Assay to Identify and Quantitate 5-hmC in Epigenome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014   Ventana Medical Systems, ... announced it has entered into an agreement with Merck ... as EMD Serono in the United States ... collaborate with Merck KGaA,s biopharmaceutical division on the development ... undisclosed target using Ventana,s proprietary diagnostic assays. In alignment ...
(Date:7/10/2014)... WOONSOCKET, R.I. , July 10, 2014 CVS ... its board of directors has approved a quarterly dividend of ... The dividend is payable on August 1, 2014, to holders ... Caremark CVS Caremark is dedicated to helping ... integrated pharmacy company in the United States ...
(Date:1/15/2014)... 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting ... China,s orthopedic instrument industry has ... size rising from 3.28 billion yuan in 2006 to ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3
... , REDWOOD CITY, Calif., July 22 ... the full results of the PAS-Port system multi-center pivotal trial, known ... the peer-reviewed publication The J ournal of Thoracic and ... from the U.S. Food and Drug Administration (FDA) in September 2008, ...
... , , SOUTH SAN FRANCISCO, ... ), a biopharmaceutical company focused on innovative oncology therapies, today announced ... new generation platinum-based chemotherapy agent and the Company,s lead product candidate. ... (FDA) to design this study, which is required for new chemical ...
Cached Medicine Technology:Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results 2Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results 3Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results 4Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing 2Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing 3
(Date:7/11/2014)... 11, 2014 Riverside Health System became the ... in Virginia in late 2012 and now, in partnership with ... residents throughout the Williamsburg and Newport News region. , Also ... and benefits to independent older adults who wish to remain ... safety net of continuing care services as well as control ...
(Date:7/11/2014)... Europe is one of the largest consumers of micro ... area. The agricultural sector is a significant user of ... the total water use. The scale and importance of ... far from negligible in most northern ones. , In ... the water use in most countries, while in the ...
(Date:7/11/2014)... July 11, 2014 Pigments are insoluble ... mainly three functions namely protective coating, opacity, and coloring. ... materials that impart color to substances such as paper, ... the pigments, which upon application impart color to the ... oxide, carbon black, and hematite. , The coloring action ...
(Date:7/11/2014)... the best available treatment for patients, from a range ... for taxpayers than the existing clinical trial process, a ... carried out while he was a member of the ... based at The University of Manchester,s Health eResearch Centre, ... ) today (Friday 11 July) looked at the use ...
(Date:7/11/2014)... Mexico (PRWEB) July 11, 2014 Experience ... the Mayan Heritage Experience Package at the luxury all-inclusive ... the package include a guided on-site ecological family tour ... well as The Coba Mayan Encounter Tour at the ... Nohoch Muul, the tallest pyramid in the Yucatan and ...
Breaking Medicine News(10 mins):Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 3Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 4Health News:Europe Micro Irrigation System Market Driven by Growing Environmental Concerns and Decreasing Water Availability - New Report by MicroMarket Monitor 2Health News:Europe Micro Irrigation System Market Driven by Growing Environmental Concerns and Decreasing Water Availability - New Report by MicroMarket Monitor 3Health News:Americas Pigments Market Worth 1,099 Thousand MT by 2018 - New Report by MicroMarket Monitor 2Health News:Americas Pigments Market Worth 1,099 Thousand MT by 2018 - New Report by MicroMarket Monitor 3Health News:Better use of electronic health records makes clinical trials less expensive 2Health News:Explore the Aura and Mystery of the Yucatan’s Mayan Culture with New Hotel Package at AAA Five Diamond Grand Velas Riviera Maya 2Health News:Explore the Aura and Mystery of the Yucatan’s Mayan Culture with New Hotel Package at AAA Five Diamond Grand Velas Riviera Maya 3
... , SHENZHEN, China, Dec. 22 /PRNewswire-FirstCall/ - Hard to ... that it has an agreement in principle to sell its ... in China. The buyer, founded in 2004, focuses on production ... Name of the buyer will be announced in a joint ...
... lifestyle on top of genetics , TUESDAY, Dec. 22 (HealthDay ... take an additional toll on sun-damaged skin, a new study ... Western Reserve Medical School in Cleveland, suggest that "people with ... same sort of sun damage," said Dr. Jonette Keri, an ...
... the University of Central Florida have found a protein that ... common and aggressive brain tumors in adults. Glioblastoma multiforme ... late U.S. Sen. Edward Kennedy, is difficult to treat because ... very quickly. About 10,000 cases are diagnosed in the United ...
... the hemophilia mutation that affected Queen Victoria and her European ... Able to trace rare genetic disease mutations, the tool can ... Now, Tel Aviv University has its own deep sequencer ... Analyzer housed in a new Genome Facility. The tool ...
... in Canada are reporting the development of a fast, ... that may exist in foods and beverages. Their paper-strip ... results in minutes rather than hours by means of ... published in ACS, Analytical Chemistry , a semi-monthly ...
... , , ATLANTA, Dec. ... the market leader in automated revenue integrity solutions that improve ... the rank of first in the Revenue Cycle - Chargemaster ... KLAS Awards: Software & Professional Services" report, published December 2009. ...
Cached Medicine News:Health News:Hard to treat Diseases (HTDS) To Sell Its MindUp BioResearch Division 2Health News:Hard to treat Diseases (HTDS) To Sell Its MindUp BioResearch Division 3Health News:Hard to treat Diseases (HTDS) To Sell Its MindUp BioResearch Division 4Health News:Sun, Smoke, Extra Weight Add Years to Skin 2Health News:Sun, Smoke, Extra Weight Add Years to Skin 3Health News:Adding a genetic supertool 2Health News:Craneware's Chargemaster Toolkit(R) Earns #1 KLAS Rank for Fourth Consecutive Year 2Health News:Craneware's Chargemaster Toolkit(R) Earns #1 KLAS Rank for Fourth Consecutive Year 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: